chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022).    No concomitant medications were provided by the reporter.  Patient received half dose.  On 04-Jun-2022 the vials were initially stored in the refrigerator.  Vial did not undergone any temperature excursions.  No treatment medications were provided by the reporter.
vaccination site warmth; vaccination site pruritis; vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION SITE PRURITUS (vaccination site pruritis) and VACCINATION SITE ERYTHEMA (vaccination site erythema) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION SITE PRURITUS (vaccination site pruritis) and VACCINATION SITE ERYTHEMA (vaccination site erythema). At the time of the report, VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION SITE PRURITUS (vaccination site pruritis) and VACCINATION SITE ERYTHEMA (vaccination site erythema) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
PT received 4th dose of Daptacel on 11/8/22. On 11/10/22 he presented to clinic with a large red rash on his deltoid where the vaccine had been administered.  Reaction to the vaccine was localized to only his arm. He did not have any respiratory symptoms or any feelings of nausea. Provider treated him with Benadryl and Tylenol. Provider drew a circle around the rash in order to track if it gets any larger.
Mom states pt was well a/administring MMR/OPV/HIB; risk assessment was done; immediately p/ vax, pt began scratching head, eyes, & trunk; skin around eyes became puffy & erythematous; raised tiny non-erythematous papules appeared on trunk;
continuous headache for 2 days; tiredness; slept a lot; Highest temp was 99.8; felt hot; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in left arm on 17Jul2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included glaucoma, hyperthyroidism, high blood pressure and gout. The patient had known allergies to scallops and tuna. The patient received unspecified medication within two weeks prior to the vaccination. The patient received other vaccines within four weeks prior to the vaccination which included varicella zoster vaccine (RZV as reported)(MANUFACTURER UNKNOWN) in the left arm on 11Jun2021 for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in left arm on 26Jun2021 at 12:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 18Jul2021, the patient experienced continuous headache for 2 days, tiredness, slept a lot, highest temperature was 99.8 and felt hot. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on 20Jul2021 after a duration of 2 days. The clinical outcome of the events tiredness, slept a lot, highest temperature was 99.8 and felt hot was recovered on an unknown date in Jul2021.
Two siblings were in for well childs. A one year old and a 4 year old. Both children needed 4 vaccines. The correct vaccines were pulled from the refrigerator and drawn up. When going to administer the vaccines in the room, the 1 year old vaccines were grabbed and given to the 4 year old. This was caught immediately after giving the shots. The parents were notified and the 1 year old received the correct vaccines. The 4 year old received a Hepatitis A and HIB that he was not due for. The local health department was contacted and told us that the extra vaccines would not harm the child.
Bells Palsy - left side facial paralysis Treatment anti viral medication, steroids, physical therapy, massage, electrical stimulation.
7 days later, red, itch swollen area around site of injection.  Lasted for 3 days.
patient was mis-administered  second covid  shot. Should have received moderna but was given pfizer. Sore arm is only reaction currently.
Within 4 hours had nausea, headache.  Lasted for about a day.  12 days later vertigo, nausea, headache resumed.  Went to primary who detected a drop in oxygen levels, was then sent to ER where many tests were done.  Included chest scan, to look for clots.  None were found.   Took dramamin for vertigo which helped.  Symptoms of nausea, headache, vertigo continue to persist off and on.  On Friday 4/23 I died my hair.  Within 2 minutes an allergic reaction too place: sudden nausea, some shaking, headache.  Took benedryl which help.  At this point, I have continued bouts of nausea and no appetite.  Its been close to a month and I'm really scared for my health.  I was completely healthy before.
Fever, chills, muscle pain and body aches started about 7 hours after the vaccine and continued for about 48 hours.
Local skin reaction. She received Dose #1 of Moderna on 8/29, then on 9/8/21 she noticed itching, redness, tenderness, warmth left upper arm below the site of the vaccine. No severe pain. No cellulitis. She was seen in our clinic on 9/14/21 with persistent redness and tenderness left arm. Supportive care with oral antihistamine and topical steroid cream recommended. Also recommended she receive Dose #2 once local skin reaction resolved.
Increasing hives which continued to intensify.  Sought medical treatment after two weeks. Treated with Prednisone - 11 day regiment of 10 mg - 3 x day for 3 days, 2 x day for 3 days, 1 x day for 3 days, 1/2 x 2 days.   Hives continued so 10 mg 2 x day for  5 days added.  Hives finally subsiding so Prednisone decreased to 5 mg 3 x day for 3 days, 2 x day for 3 days, 1 x day for 2 days.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 53 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Bronchiectasis" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa. Concomitant medication(s) included: OMEPRAZOLE; TYLENOL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: Treatment of COVID-19; (unspecified date) negative, notes: Day 10 Had negative test on day 8; (15Dec2022) positive, notes: positive test 4 days after  stopping Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Therapeutic measures for covid 19 included anti-viral Paxlovid from 07Dec2022 to 11Dec2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Inflammation of gums and ulcers/sores on gums, tongue, and top lip. Sores were not near teeth (mostly attached gingivae if I'm reading diagrams correctly) I noticed a single small ulcer prior to receiving vaccine so I am not certain it is related to the vaccination, but following vaccine administration, many (10+) ulcers developed, with 2 larger than 0.5 cm. There was also inflammation of the gum tissue and a couple sore spots on my tongue.  The condition worsened from 12/12 to approximately 12/19 and plateaued at that point.  I tried gargling with salt water and applying drops of oregano oil to relieve pain, but the sores did not improve On 12/22, I went to a periodontist who chemically cauterized some of the ulcers and prescribed an antibacterial mouthwash to use twice per day. He also recommended stress reduction and sleep. He thought it could be an immune response to a latent virus (I believe he described it similar to a cold sore, but a different virus) brought on by psychological and physical stress.  The cauterization relieved ~75% of the pain within an hour of treatment. The pain was 95% improved by 12/24. As of today (12/27/2021), there is no pain and the ulcers are healing, but there is still some redness/inflammation.
Initial symptom was aching bone and joint pain in L acromion. This pain progressed over 12 hrs to include L clavicle, L neck, L scapula, L arm.  At this time majority of the pain is in L acromioclavicular joint and L upper back.  Pain increases great with lifting of L arm.  Range of motion is mildly affected due to pain at this time.
Swelling at site of injection r upper arm. Area is mildly tender and itchy.
patient had a reaction; Initial information received on 23-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a male patient of an unknown age who had a reaction (adverse event), while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious patient had a reaction (adverse event) (Unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was patient had a reaction.  It was not reported if the patient received a corrective treatment.  The outcome of the event was reported as Unknown.  The caller has three children, ages 7, 9, and 11. One of the children received DTaP in the past and had a reaction. After that, the mom and physician decided to delay DTP immunization of the three children until the youngest is age 7. All three children received Sanofi Tdap about 4 weeks ago. It was the first dose for two of the children. It was the second dose of one of the children. Lot --C5609AA expiry 04-Apr-2021 and concomitant medication MMR.  Information on the batch number was requested.  Documents held by sender: none.
Client was given Proquad instead of individual Varicella and MMR. No problems noted.
On 11/13/00, this patient received: DTaP, Comvax, IPV, and Prevnar. On 01/01, the mother noticed poor eye contact, decreased appetite, spasticity mostly in lower extremities, progressive development delay.
Fatigue, mild fever, chills, body ache on , 4/24, the day after vaccination. Slight pain on the site of injection.
About 6 hours after injection, sore arm At 3am awoke from sleep shivering uncontrollably.  This went on for about 2 hours. Woke at 6am with muscle aches and temp 101.2. Took Tylenol.  About 11am took temp - 100.1.   Took several naps and laid around most of the day not feeling well.  Temp went back to normal.  12/26 woke feeling fine, but took morning nap and afternoon nap, and still did not feel back to normal; tired. No fever and slight muscle aches.  12/27 feel back to normal.
received booster 0.25mL instead of third dose 0.5mL; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (received booster 0.25mL instead of third dose 0.5mL) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In August 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In August 2021, the patient experienced ACCIDENTAL UNDERDOSE (received booster 0.25mL instead of third dose 0.5mL). In August 2021, ACCIDENTAL UNDERDOSE (received booster 0.25mL instead of third dose 0.5mL) had resolved.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Patient was immunocompromised.
Swelling and rash/hives. Itching at rash sight and minimal redness.
extreme chest pain, shortness of breath, headache, blurred vision, overall fatigue and nausea and dehydration. started within 10 minutes after shot and symptoms lasted about 4 days.
Moderna COVID-19 Vaccine EUA Redness around injection site 3 inches in diameter  Swelling around injection site 3 inches in diameter  Itching  Tenderness
Side effects from booster; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (Side effects from booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects from booster). At the time of the report, VACCINATION COMPLICATION (Side effects from booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter. Treatment information was not provided by the reporter. Patient enquired about, to get a double dosage on booster if immunocompromised.
My arm was sore on fire. I couldn't lift it up. It was in pain for 2 days after the shot. My right thumb also wouldn't stop jerking and spazzing. No fever or any other side effects except right arm and right finger.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 21-NOV-2015 at time- 00:07, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.4 and 2.9 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Narrative:  Patient presented to the ED on 9/28/2021 with chief complaint of sudden onset of shortness of breath and shortness of breath. Initial troponin was 0.19. EKG was negative for ischemic changes. Repeat troponin increased to 0.26. Patient tested POSITIVE for COVID. He was declined for transfer to cath lab due to COVID status. He was diagnosed with NSTEMI and admitted to ICU for close monitoring. On day #2 of hospitalization, Patient develop diffuse body aches and mild fever. He did not require oxygen and was not placed on dexamethasone or remdesivir.
Also had the second one and his allergies were much worse; He ended up having flu like symptoms 12 hours afterwards and cough.; He ended up having flu like symptoms 12 hours afterwards and cough.; The day before yesterday he had a lot of breathing issues that were so bad he had to get a updraft of Albuterol to help; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via intramuscular route of administration in left arm on 11Jan2021 (Lot number: EJ1685, Expiration Date: not reported), at the age of 28-years, as single dose for COVID-19 Immunisation. Patient medical history includes ongoing allergy. Patient concomitant medication was not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via unspecified route of administration, administered to left arm on 21Dec2020 at 8:30 AM (Lot number: EJ1685, Expiration Date: not reported), as single dose for COVID-19 Immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. After receiving second dose of vaccine patient did not think much of it and his allergies. Knows some have allergies worse than others. On an unknown date in Jan2021, patient allergies were much worse, patient experienced flu like symptoms 12 hours afterwards and cough. It is been a month and he still have cough, the day before yesterday he had a lot of breathing issues that were so bad, he had to get an updraft of Albuterol to help. Treatment received by Albuterol to help and steroid injection. Patient had to visit saw the primary care provider and she gave him a steroid injection and it seemed to help quite a bit also. He still has some other minor issues, but they are not so bad. Again, mentions the primary care provider stated the other patients had to be seen and they had delayed reactions as well. He is not so bad since he got the steroid. He enquires any other thing he should do as far as treatment he should receive. Recommended caller to consult medical provider for further medical advice. The outcome of the event breathing issues was unknown. The outcome of rest all the events was not recovered.   Follow-up attempts are completed. No further information is expected.
10 mm diameter area of erythema on LT deltoid around immunization site. Instructed to apply cool compresses and call if area increases.
Flu Vaccine given 11/11/21 - muscle soreness for 2 days, then on 11/13/21, severe pain started  in shoulder and has worsened every day since then.  Arthritis strength Tylenol does not help with pain.  Called doctor's office 11/18/21 to report problem and was prescribed a medrol pack.
Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 12Apr2021 (Lot number: ER8730, Expiration Date: 31Jul2021) at the age of 33 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1ST DOSE, SINGLE), administration date: 16Mar2021, when the patient was 33 years old, for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset Apr2021, outcome "recovering", described as "Chills". Therapeutic measures were not taken as a result of chills.  No follow-up attempts are possible. No further information is expected.